Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

NCT02828540 is registered in ClinicalTrials.gov with Hocheol Kim as lead sponsor.

NCT NCT02828540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02828540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase II Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke
Lead sponsor
Hocheol Kim
Phase
Phase 2
Overall status
Completed
Start date
August 4, 2016
Completion date
August 3, 2018
Enrollment
78 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke